- Home
- Life Sciences
- Pharmaceutical
- Pharmaceutical Analysis & Statistics in North America Countries, November 2012 (p57)
Talk to Geoffrey
(866) 682 9815
Search inside this page
Publication dates
Publishers
- Global Data (2 858)
- Global Markets Direct (1 773)
- Ibisworld (25)
- Business Monitor International (39)
- Global Research & Data Services (43)
-
- Barnes Reports (32)
- Canadean Ltd (14)
- Euromonitor International (78)
- ICD Research (103)
- GBI Research (41)
- KnowMade (2)
- Aruvian's R'search (10)
- Axis Research Mind (1)
- BCC Research (19)
- Daedal Research (3)
- Firstword Pharma (12)
- Global Industry Analysts (1)
- Infiniti Research Limited (6)
- Koncept Analytics (22)
- Timetric (2)
- TriMark Publications (12)
- Datamonitor (351)
- MarketLine (180)
- Life Science Analytics (LSA) (151)
- Espicom Business Intelligence (74)
- Frost & Sullivan (63)
- Business Review (59)
- Timely Data Resources Inc. (52)
- Global Industry Analyst (49)
- SCRIP Insights (45)
- Mintel (33)
- World Market Intelligence Ltd (29)
- Kalorama Information (25)
- CHI Insight Pharma Reports (24)
- The Assessment Group (19)
- Visiongain (18)
- Freedonia (17)
- VacZine Analytics Group Of Assay Advantage Ltd (14)
- MarketLine Industry Guides (12)
- Sociable Pharma (10)
- RNCOS (9)
- La Merie Publishing (8)
- MarketsandMarkets (8)
- Packaged Facts (8)
- IData Research, Inc. (8)
- Ken Research Private (7)
- ABMRG (6)
- Bioseeker (6)
- Obainfo (4)
- BioPharm Reports (4)
- Apollo Managed Care Consultants (3)
- Arrowhead (3)
- DrugPatentWatch - ThinkBiotech LLC (3)
- Greystone Research Associates (3)
- Leatherhead Food Research (3)
- Renub Research (3)
- Urch Publishing (3)
- BioInformatics (2)
- Pacific Bridge Medical (2)
- Red Mountain Insights (2)
- Venture Planning Group (2)
- Analytiqa (1)
- Arena (1)
- Beremans Ltd (1)
- BioPlan Associates, Inc. (1)
- France Innovation Scientifique et Transfert (1)
- Industry Experts (1)
- Innovative Research and Products (iRAP), Inc. (1)
- International Market Analysis Research and Consult (1)
- PMR Ltd. (1)
- Research In China (1)
- Transparency Market Research (1)
- Verdict Research Ltd (1)
- WinterGreen Research (1)
- Zzz FACT Research (1)
All regions
data types
Free Market Research Guides to Download
Pharmaceutical Analysis & Statistics in North America Countries, November 2012 (p57)
You might be interested in: therapeutics, cancer, drug, more »
» Purchase Premium Reports
1681-1710 of about 5 700 reports
Arno Therapeutics, Inc. (ARNI) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary Arno Therapeutics, Inc. (Arno Therapeutics) is a biopharmaceutical company. It undertakes the development of innovative products for the treatment of cancer. The company focuses on acquiring the ...
- Industries : Therapy
- Countries : United States
Nile Therapeutics, Inc. (Symbol:NLTX) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Therapy
- Countries : United States
Inhibitex, Inc. (Symbol:INHX) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pathology
- Countries : United States
Siegfried Holding AG (Symbol:SFZN) SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug and Medication
- Countries : Switzerland, China, United States
Sopharma AD Sofia (3JR ) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary Sopharma AD Sofia (Sopharma) is a pharmaceutical company. It carries out the development, manufacturing and commercialization of medicinal substances and finished dosage forms. The company's products ...
- Industries : Pharmaceutical
- Countries : Poland, Turkey, United States, World
Medivation, Inc. (Symbol:MDVN) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pathology
- Countries : United States
Senju Pharmaceutical Co., Ltd. SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : United States, Japan
QRxPharma Limited (Symbol:QRX) SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug Discovery and Development
- Countries : Australia, United States
Skinvisible, Inc. (Symbol:SKVI) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug and Medication
- Countries : United States
DUSA Pharmaceuticals, Inc (Symbol:DUSA) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : United States
Genta Incorporated (GNTA) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary Genta Incorporated (Genta) is a bio-pharmaceutical company that carries out the identification, development and commercialization of drugs for the treatment of cancer and related diseases. The ...
- Industries : Drug Discovery and Development
- Countries : United States
EKR Therapeutics, Inc. SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Therapy
- Countries : United States
OSI Pharmaceuticals, Inc. (Symbol:OSIP) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : United States
Icagen, Inc. - Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary Icagen, Inc. (Icagen) is a biopharmaceutical company involved in discovering, developing and commercializing orally administered small molecule drugs that modulate ion (sodium, potassium, calcium ...
- Industries : Pharmaceutical
- Countries : United States
Prestige Brands Holdings, Inc. (Symbol:PBH) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Over-the-counter Drug
- Countries : United States
Orexigen Therapeutics, Inc. (Symbol:OREX) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Therapy
- Countries : United States
Shoppers Drug Mart Corporation (Symbol:SC) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
Shoppers Drug Mart Corporation (Shoppers Drug) is licensor of full-service retail drug stores. The company is involved in operating full-service retail drug stores, under the brand Shoppers Drug Mart ...
- Industries : Drug and Medication
- Countries : Canada, United Kingdom
CytoGenix, Inc. (Symbol:CYGX) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug and Medication
- Countries : United States
Novo Nordisk A/S (NOVO B) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary Novo Nordisk A/S (Novo Nordisk) is a global healthcare company. It undertakes the development, manufacture and marketing and distribution of diabetes care products. The company also develops drugs ...
- Industries : Pathology
- Countries : United States
Synta Pharmaceuticals Corp. (Symbol:SNTA) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : United States
ProPhase Labs. Inc. (Symbol:PRPH) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Over-the-counter Drug
- Countries : United States
Adherex Technologies Inc. (Symbol:AHX) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Therapy
- Countries : United States
H. Lundbeck A/S (LUN) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary H. Lundbeck A/S (Lundbeck) is a pharmaceutical company, involved in the research, development, manufacturing and marketing of pharmaceuticals for the treatment of diseases related to the central ...
- Industries : Pathology
- Countries : Europe, Denmark, United States
Proteo, Inc. (Symbol:PTEO) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug and Medication
- Countries : United States
Advanced Life Sciences Holdings, Inc. (ADLS) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary Advanced Life Sciences Holdings, Inc. (Advanced Life Sciences) engages in the discovery, development, and commercialization of drugs in the areas of infectious disease, inflammation, and oncology. ...
- Industries : Pathology
- Countries : United States
BioDelivery Sciences International, Inc. (Symbol:BDSI) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug Delivery Technology
- Countries : United States
Matrixx Initiatives, Inc. (Symbol:MTXX) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug and Medication
- Countries : United States
Insmed Incorporated (Symbol:INSM) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pathology
- Countries : United States
Hemispherx Biopharma, Inc. (Symbol:HEB) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Therapy
- Countries : United States
Neurologix, Inc. (Symbol:NRGX) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pathology
- Countries : United States
» Download Public Reports
About 16 000 reports
Company Report: Pathology in The United States and Ireland for Year 2013
- Company report
- May 2013
- 5 pages
- by Corporation
... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...
U.s. Pharmaceutical Industry
May 2013U.s. Vitamin D Sector Analysis
May 2013» Read our Company Profiles
About 200 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandGlaxoSmithKline PLC
United KingdomJohnson and Johnson
United StatesEli Lilly and Co.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
